New dry eye drug is first that aims to treat cause, rather than symptoms

Gordon Laurie of the UVA School of Medicine’s Department of Cell Biology has developed a new potential treatment for dry eye, with human testing to start in March. The drug differs from other treatments of dry eye in that it aims to treat the cause of dry eye instead of masking the symptoms. Read the article in UVA Today here.